Description
Details
Product Overview:
BIOMYC™-3 Antibiotic Solution is a treatment based on the antibiotic Ciprofloxacin. This antibiotic belongs to the Fluoroquinolone group that inhibits synthesis of the enzyme DNA gyrase, which is responsible for supercoiling in bacterial DNA. The treatment consists of adding the antibiotic to the growth medium for 14 days and changing the medium every three days. On completion of the treatment, the cells should be grown on media without antibiotics for at least two weeks and then re-tested for the presence of mycoplasma. If the culture tests positive, the course of treatment should be repeated.
Treatment with Ciprofloxacin does not damage or alter the cells. This antibiotic should not be used repeatedly in cell cultures; otherwise, the mycoplasma is liable to develop resistance to it.
Recommended Use:
- Add 1 ml BIOMYC-3 to 100 ml medium.
- Continue the treatment for a total of 14 days, while changing the medium (containing BIOMYC-3) every 2-3 days.
- Retain the cells in the growth medium for an additional 12 days before re-testing for mycoplasma
Learn more by visiting our BIOMYC Antibiotic Selection Guide
Specifications
Specifications
QTY | 100 mL |
---|---|
Brand | BIOMYC™ |
Storage Conditions | -20º |
Shipping Conditions | Dry Ice |
References
references
- Q. Chen, et al. Immune-enhancing effects of a polysaccharide PRG1-1 from Russula griseocarnosa on RAW264.7 macrophage cells via the MAPK and NF-κB signalling pathways, Food and Agricultural Immunology, (2018) 29:1, 833-844, DOI: 10.1080/09540105.2018.1461198
- Q. Zhang, et al. Entry Dynamics of Single Ebola Virus Revealed by Force Tracing. ACS Nano ,May 8, 2020 DOI: 10.1021/acsnano.0c01739
Documentation
Materials Safety Data Sheet
Manuals and Protocols
Certificate of Analysis
COA's can be downloaded from Sartorius's Certificates Portal.
For certificates issued before November 15, 2021, please enter below the product lot number and click search.